Assembly Biosciences (ASMB)
14.87 -0.08 (-0.54%) 01/23/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Thu, Jan 23rd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Sales | 6,845 | 8,533 | 5,785 | 0 | 0 |
Gross Profit | 6,845 | 8,533 | 5,785 | N/A | N/A |
Operating Expenses | 17,801 | 20,736 | 16,514 | 19,714 | 15,048 |
Operating Income | -10,956 | -12,203 | -10,729 | -12,551 | -15,048 |
Other Income | 1,343 | 1,457 | 1,652 | 1,622 | 628 |
Pre-tax Income | -9,613 | -10,746 | -9,077 | -10,929 | -14,420 |
Income Tax | N/A | 406 | N/A | N/A | N/A |
Net Income Continuous | -9,613 | -11,152 | -9,077 | -10,962 | -14,420 |
Net Income | $-9,613 | $-11,152 | $-9,077 | $-10,962 | $-14,420 |
EPS Basic Total Ops | -1.51 | -1.98 | -1.66 | -1.75 | -3.29 |
EPS Basic Continuous Ops | -1.51 | -1.98 | -1.66 | -1.75 | -3.29 |
EPS Diluted Total Ops | -1.51 | -1.98 | -1.66 | -1.75 | -3.29 |
EPS Diluted Continuous Ops | -1.51 | -1.98 | -1.66 | -1.75 | -3.29 |
EPS Diluted Before Non-Recurring Items | -1.51 | -1.98 | -1.66 | N/A | -3.24 |
EBITDA(a) | $-11,764 | $-13,131 | $-11,961 | $-20,681 | $-15,245 |